SAM
UTHR icon

Storebrand Asset Management’s United Therapeutics UTHR Stock Holding History

Storebrand Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.7M Sell
91,690
-2,053
-2% -$1.16M 0.12% 165
2026
Q1 		$55.6M Sell
93,743
-61
-0.1% -$30.4K 0.16% 137
2025
Q4 		$45.7M Buy
93,804
+11,062
+13% +$5.15M 0.12% 163
2025
Q3 		$34.7M Sell
82,742
-8,841
-10% -$2.97M 0.09% 204
2025
Q2 		$26.3M Sell
91,583
-3,003
-3% -$897K 0.08% 239
2025
Q1 		$29.2M Sell
94,586
-972
-1% -$333K 0.09% 205
2024
Q4 		$33.7M Sell
95,558
-3,617
-4% -$1.33M 0.1% 196
2024
Q3 		$35.5M Sell
99,175
-13,394
-12% -$4.52M 0.11% 197
2024
Q2 		$35.9M Buy
112,569
+423
+0.4% +$112K 0.12% 186
2024
Q1 		$25.8M Sell
112,146
-2,003
-2% -$452K 0.09% 230
2023
Q4 		$25.1M Sell
114,149
-1,070
-0.9% -$247K 0.09% 238
2023
Q3 		$26M Sell
115,219
-2,984
-3% -$687K 0.12% 192
2023
Q2 		$26.1M Sell
118,203
-3,719
-3% -$824K 0.12% 197
2023
Q1 		$27.3M Sell
121,922
-3,511
-3% -$866K 0.14% 190
2022
Q4 		$34.9M Hold
125,433
– – 0.19% 140
2022
Q3 		$26.3M Buy
125,433
+19,950
+19% +$4.46M 0.16% 162
2022
Q2 		$24.9M Hold
105,483
– – 0.14% 176
2022
Q1 		$18.9M Sell
105,483
-2,500
-2% -$476K 0.09% 256
2021
Q4 		$23.3M Buy
107,983
+1,125
+1% +$221K 0.1% 231
2021
Q3 		$19.7M Sell
106,858
-155
-0.1% -$30.5K 0.1% 251
2021
Q2 		$19.2M Sell
107,013
-2,476
-2% -$472K 0.09% 268
2021
Q1 		$18.3M Buy
109,489
+7,270
+7% +$1.21M 0.1% 249
2020
Q4 		$15.5M Buy
102,219
+2,048
+2% +$269K 0.09% 254
2020
Q3 		$10.1M Sell
100,171
-645
-0.6% -$70.8K 0.07% 278
2020
Q2 		$12.2M Sell
100,816
-5,944
-6% -$669K 0.1% 214
2020
Q1 		$10.1M Buy
+106,760
New +$10.1M 0.11% 216

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Storebrand Asset Management's UTHR Position: Q2 2026 in Review

Storebrand Asset Management reduced its United Therapeutics (UTHR) stake by 2.2% in Q2 2026, selling an estimated $1.16M and leaving 91,690 shares worth $49.7M. The position accounts for 0.12% of the portfolio, ranked #165.

Storebrand Asset Management first reported a position in UTHR in Q1 2020 and has held it in 26 quarters since. The position peaked at $55.6M in Q1 2026. 818 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Storebrand Asset Management held 91,690 shares of United Therapeutics worth $49.7M as of Q2 2026.
  • Storebrand Asset Management sold 2,053 United Therapeutics shares in Q2 2026, an estimated $1.16M.
  • United Therapeutics made up 0.12% of Storebrand Asset Management's portfolio in Q2 2026, its #165 holding.
  • Storebrand Asset Management first reported a position in United Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Storebrand Asset Management's United Therapeutics position peaked at $55.6M in Q1 2026.
  • 818 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Storebrand Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.